| 영문 | genetic engineering | 한글 | 유전공학 |
|---|---|---|---|
| 설명 | 1. 유전자의 합성이나 변형 따위를 연구하는 학문. 응용 유전학의 한 분야로, 병의 치료나 이로운 산물의 대량 생산을 목적으로 한다. 2. 생물의 유전자를 인공적으로 가공하여 인간에게 필요한 물질을 대량으로 값싸게 얻는 기술. 1970년대에 들어서면서 경이적인 과학기술의 하나로 큰 주목을 끌고 있으며, 이 분야에는 재조합 DNA기술-세포융합기술 및 핵치환기술 등이 있다. 재조합 DNA 기술에 의하여 인공적으로 재조합유전자를 만든 최초의 보고는 1972년 잭슨 등이 하였고, 인공적 재조합유전자를 숙주세포에서 형질을 발현시키는 데 최초로 성공한 것은 1973년 F. J. 코벤 등이다. 이 재조합 DNA 기술은 세균파지, 플라스미드에 관한 연구와 DNA에 작용하는 효소들, 특히 제한효소와 DNA 연결효소에 관한 연구에 의존하였다. 유전공학의 발전은 우리 세계를 바꿀 수 있을 것으로 내다보고 있다. 암을 제압하고 노화를 방지할 수 있어 유전공학은 결국 오늘의 인간이 안고 있는 에너지-식량-의료 등의 문제를 해결해 줄 수 있는 가능성을 지닌다. 이 때문에 유전공학은 ‘제3의 산업혁명’이라고 할 수 있고, 따라서 그 개발을 위하여 온 세계의 기업들이 이의 연구개발에 착수하고 국가들도 전략기술로 다루어 집접 육성에 박차를 가하고 있다. 우리나라에서도 1982년부터 유전공학 분야를 국가가 육성해야 할 특정연구 분야로 지정하고 있다. |
||
| PRO | peer review organization; physician review organization; Professional Review Organization; pronation... |
|---|---|
| BMS | Bachelor of Medical Science; betamethasone; biomedical monitoring system; biomedical science; bleomy... |
| BEB | Biomedical Engineering Branch [of US Army] |
| CABMET | Colorado Association of Biomedical Engineering Technicians |
| SBET | Society for Biomedical Engineering Technicians |
| ATP | Annual Transmission Potential |
|---|---|
| DUR | Drug Use Review |
| DUR | Drug Utilization Review |
| IRB | Institutional Review Board |
| MEDPAR | Medicare Provided Analysis and Review |
institution (기관, 제도
| biomedical engineering | <orthopaedics> The use of engineering technology, instrumentation and methods to solve medical problems, such as improving our understanding of physiology and the manufacture of artificial limbs and organs. (21 Mar 1998) |
|---|---|
| annual | <biology, plant biology> Describes a plant or other organism that completes its whole life cycle in one year Occuring yearly. (09 Oct 1997) |
| annual reports | Annual statements concerning the administrative and operational functions of an institution or organization. (12 Dec 1998) |
| mean annual increment | The annual average growth rate for a tree, computed over its entire life cycle. (05 Dec 1998) |
| excess annual growth | The amount by which new forest growth exceeds removal in a year. The annual quantity of wood produced in a forest in excess of market demand. (05 Dec 1998) |
| biomedical | 1. Pertaining to those aspects of the natural sciences, especially the biologic and physiologic sciences, that relate to or underlie medicine. 2. Biological and medical, i.e., encompassing both the science(s) and the art of medicine. (05 Mar 2000) |
| biomedical and dental materials | Substances used in biomedicine or dentistry predominantly for their physical, as opposed to chemical, properties. (12 Dec 1998) |
| biomedical model | A conceptual model of illness that excludes psychological and social factors and includes only biological factors in an attempt to understand a person's medical illness or disorder. (05 Mar 2000) |
| technology assessment, biomedical | Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems. (12 Dec 1998) |
| biological engineering | <agriculture> A type of artificial selection, the creation of plant or animal breeds that are agriculturally or industrially useful. Compare: natural selection. (21 Mar 1998) |
| biotechnical engineering | Civil engineering methods incorporating organic materials to produce functional structures that are also aesthetically pleasing, provide wildlife habitat, and provide sites for revegetation. (09 Oct 1997) |
| maintenance and engineering, hospital | Hospital department whose primary function is the upkeep and supervision of the buildings and grounds and the maintenance of hospital physical plant and equipment which requires engineering expertise. (12 Dec 1998) |
| genetic engineering | <molecular biology, technique> General term covering the use of various experimental techniques to produce molecules of DNA containing new genes or novel combinations of genes, usually for insertion into a host cell for cloning. (07 May 1998) |
| genetic engineering technologies | See: recombinant DNAtechnologies. (09 Oct 1997) |
| cellular engineering | <technique> The use of techniques for constructing replacement or additional or experimental parts of cells and tissues for both fundamental investigation and as prosthetic devices. Often involves the interfacing of cells and nonliving structures. (26 Mar 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|